1. Home
  2. AVTX vs BYFC Comparison

AVTX vs BYFC Comparison

Compare AVTX & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • BYFC
  • Stock Information
  • Founded
  • AVTX 2011
  • BYFC 1946
  • Country
  • AVTX United States
  • BYFC United States
  • Employees
  • AVTX N/A
  • BYFC N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • AVTX Health Care
  • BYFC Finance
  • Exchange
  • AVTX Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • AVTX 57.4M
  • BYFC 63.8M
  • IPO Year
  • AVTX 2015
  • BYFC 1996
  • Fundamental
  • Price
  • AVTX $4.73
  • BYFC $6.20
  • Analyst Decision
  • AVTX Strong Buy
  • BYFC
  • Analyst Count
  • AVTX 7
  • BYFC 0
  • Target Price
  • AVTX $31.00
  • BYFC N/A
  • AVG Volume (30 Days)
  • AVTX 89.2K
  • BYFC 3.8K
  • Earning Date
  • AVTX 08-11-2025
  • BYFC 07-29-2025
  • Dividend Yield
  • AVTX N/A
  • BYFC N/A
  • EPS Growth
  • AVTX N/A
  • BYFC N/A
  • EPS
  • AVTX N/A
  • BYFC N/A
  • Revenue
  • AVTX $441,000.00
  • BYFC $32,732,999.00
  • Revenue This Year
  • AVTX N/A
  • BYFC N/A
  • Revenue Next Year
  • AVTX N/A
  • BYFC N/A
  • P/E Ratio
  • AVTX $0.69
  • BYFC N/A
  • Revenue Growth
  • AVTX N/A
  • BYFC N/A
  • 52 Week Low
  • AVTX $3.39
  • BYFC $4.68
  • 52 Week High
  • AVTX $16.00
  • BYFC $9.46
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 57.87
  • BYFC 38.34
  • Support Level
  • AVTX $4.46
  • BYFC $6.00
  • Resistance Level
  • AVTX $4.90
  • BYFC $6.68
  • Average True Range (ATR)
  • AVTX 0.37
  • BYFC 0.14
  • MACD
  • AVTX 0.09
  • BYFC -0.01
  • Stochastic Oscillator
  • AVTX 88.61
  • BYFC 0.00

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: